Julie Rubinstein Adaptive Biotechnologies Corp (ADPT) insider trading activity

ADPT Quotes by TradingView

Julie Rubinstein is President of Adaptive Biotechnologies Corp. Currently has a direct ownership of 472,754 shares of ADPT, which is worth approximately $2.51 Million. The most recent transaction as insider was on Jan 08, 2021, when has been sold 8,814 shares (Common Stock) at a price of $59.96 per share, resulting in proceeds of $528,487. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 473K
0% 3M change
40.36% 12M change
Total Value Held $2.51 Million

JULIE RUBINSTEIN Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 08 2021
SELL
Open market or private sale
$528,487 $59.96 p/Share
8,814 Reduced 100.0%
0 Common Stock
Jan 08 2021
BUY
Exercise of conversion of derivative security
$94,800 $6.32 p/Share
15,000 Added 50.0%
15,000 Common Stock
Jan 08 2021
BUY
Open market or private sale
$373,882 $60.44 p/Share
6,186 Added 55.58%
4,944 Common Stock
Jan 07 2021
SELL
Open market or private sale
$859,500 $57.3 p/Share
15,000 Reduced 100.0%
0 Common Stock
Jan 07 2021
BUY
Exercise of conversion of derivative security
$94,800 $6.32 p/Share
15,000 Added 50.0%
15,000 Common Stock
Jan 06 2021
SELL
Open market or private sale
$827,400 $55.16 p/Share
15,000 Reduced 100.0%
0 Common Stock
Jan 06 2021
BUY
Exercise of conversion of derivative security
$94,800 $6.32 p/Share
15,000 Added 50.0%
15,000 Common Stock
Jan 05 2021
SELL
Open market or private sale
$844,050 $56.27 p/Share
15,000 Reduced 100.0%
0 Common Stock
Jan 05 2021
BUY
Exercise of conversion of derivative security
$94,800 $6.32 p/Share
15,000 Added 50.0%
15,000 Common Stock
Jan 04 2021
SELL
Open market or private sale
$866,550 $57.77 p/Share
15,000 Reduced 100.0%
0 Common Stock
Jan 04 2021
BUY
Exercise of conversion of derivative security
$94,800 $6.32 p/Share
15,000 Added 50.0%
15,000 Common Stock
Dec 31 2020
SELL
Open market or private sale
$875,400 $58.36 p/Share
15,000 Reduced 100.0%
0 Common Stock
Dec 31 2020
BUY
Exercise of conversion of derivative security
$94,800 $6.32 p/Share
15,000 Added 50.0%
15,000 Common Stock
Dec 30 2020
SELL
Open market or private sale
$897,450 $59.83 p/Share
15,000 Reduced 100.0%
0 Common Stock
Dec 30 2020
BUY
Exercise of conversion of derivative security
$94,800 $6.32 p/Share
15,000 Added 50.0%
15,000 Common Stock
Dec 29 2020
SELL
Open market or private sale
$907,650 $60.51 p/Share
15,000 Reduced 100.0%
0 Common Stock
Dec 29 2020
BUY
Exercise of conversion of derivative security
$94,800 $6.32 p/Share
15,000 Added 50.0%
15,000 Common Stock
Dec 28 2020
SELL
Open market or private sale
$938,250 $62.55 p/Share
15,000 Reduced 100.0%
0 Common Stock
Dec 28 2020
BUY
Exercise of conversion of derivative security
$94,800 $6.32 p/Share
15,000 Added 50.0%
15,000 Common Stock
Dec 24 2020
SELL
Open market or private sale
$958,350 $63.89 p/Share
15,000 Reduced 100.0%
0 Common Stock
Dec 24 2020
BUY
Exercise of conversion of derivative security
$94,800 $6.32 p/Share
15,000 Added 50.0%
15,000 Common Stock
Dec 23 2020
SELL
Open market or private sale
$969,450 $64.63 p/Share
15,000 Reduced 100.0%
0 Common Stock
Dec 23 2020
BUY
Exercise of conversion of derivative security
$94,800 $6.32 p/Share
15,000 Added 50.0%
15,000 Common Stock
Dec 22 2020
SELL
Open market or private sale
$959,850 $63.99 p/Share
15,000 Reduced 100.0%
0 Common Stock
Dec 22 2020
BUY
Exercise of conversion of derivative security
$94,800 $6.32 p/Share
15,000 Added 50.0%
15,000 Common Stock
JR

Julie Rubinstein

President
Seattle, WA

Track Institutional and Insider Activities on ADPT

Follow Adaptive Biotechnologies Corp and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ADPT shares.

Notify only if

Insider Trading

Get notified when an Adaptive Biotechnologies Corp insider buys or sells ADPT shares.

Notify only if

News

Receive news related to Adaptive Biotechnologies Corp

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ADPT